ISDA: 2YNG

Deposition Date 2012-10-14

Release Date 2013-01-09

Last Version Date 2023-12-20

Entry Detail

PDB ID:

2YNG

Keywords:

HYDROLASE

Title:

HIV-1 Reverse Transcriptase in complex with inhibitor GSK560

Biological Source:

Source Organism:

HIV-1 M\:B_HXB2R (Taxon ID: 11706)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.12 Å

R-Value Free:

0.24

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:REVERSE TRANSCRIPTASE/RIBONUCLEASE H
Gene (Uniprot):gag-pol
Chain IDs:A
Chain Length:563
Number of Molecules:1
Biological Source:HIV-1 M\:B_HXB2R

UniProt ID:P04585 Pfam ID:PF00078, PF06817, PF06815, PF00075

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:P51 RT
Gene (Uniprot):gag-pol
Chain IDs:B
Chain Length:447
Number of Molecules:1
Biological Source:HIV-1 M\:B_HXB2R

UniProt ID:P04585 Pfam ID:PF00078, PF06817, PF06815, PF00075

Ligand Molecules

SRT

WHU

Primary Citation

Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase.

Chong, P, Sebahar, P, Youngman, M, Garrido, D, Zhang, H, Stewart, E.L, Nolte, R.T, Wang, L, Ferris, R.G, Edelstein, M, Weaver, K, Mathis, A, Peat, A.Show

J.Med.Chem. 55 10601 ? (2012)

PMID: 23137340 DOI: 10.1021/JM301294G

Abstact

A new series of non-nucleoside reverse transcriptase inhibitors based on an imidazole-amide biarylether scaffold has been identified and shown to possess potent antiviral activity against HIV-1, including the NNRTI-resistant Y188L mutated virus. X-ray crystallography of inhibitors bound to reverse transcriptase, including a structure of the Y188L RT protein, was used extensively to help identify and optimize the key hydrogen-bonding motif. This led directly to the design of compound 43 that exhibits remarkable antiviral activity (EC50<1 nM) against a wide range of NNRTI-resistant viruses and a favorable pharmacokinetic profile across multiple species.

Legend

Protein

Chemical

Disease

Primary Citation of related structures